87
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease

&
Pages 547-552 | Published online: 16 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jing Xie, Chang Chen, Li-juan Hou, Chan-juan Zhou, Liang Fang & Jian-jun Chen. (2020) Dual Metabolomic Platforms Identified a Novel Urinary Metabolite Signature for Hepatitis B Virus-Infected Patients with Depression. Diabetes, Metabolic Syndrome and Obesity 13, pages 1677-1683.
Read now
Trevor R. Norman & James S. Olver. (2019) Agomelatine for depression: expanding the horizons?. Expert Opinion on Pharmacotherapy 20:6, pages 647-656.
Read now
Tingting Che, Xiaochun Teng, Qun Huang, Yanfei Mu, Xianjun Tang, Xiaosong Mu & Youneng Wei. (2018) Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial. Neuropsychiatric Disease and Treatment 14, pages 1527-1533.
Read now

Articles from other publishers (9)

Nevertyty M. Mahmoud, Shimaa M. Elshazly, Arwa A. Hassan & Eman Soliman. (2023) Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway. International Immunopharmacology 115, pages 109646.
Crossref
Christina J. Pearce, Natalie Hall, Joanna L. Hudson, Ken Farrington, Madeleine J. Ryan Tucker, David Wellsted, Julia Jones, Shivani Sharma, Sam Norton, Paula Ormandy, Nick Palmer, Anthony Quinnell, Lauren Fitzgerald, Sophie Griffiths & Joseph Chilcot. (2023) Approaches to the identification and management of depression in people living with chronic kidney disease: A scoping review of 860 papers. Journal of Renal Care.
Crossref
Fadhil A-Hamad Saleh-Arong, Nattaphon Chokemaitree, Naowanit Nata, Pamila Tasanavipas, Narittaya Varothai & Bancha Satirapoj. (2022) EFFECT OF AGOMELATINE AND SERTRALINE ON PATIENTS WITH MAJOR DEPRESSIVE DISORDERS AND CHRONIC KIDNEY DISEASE: A RANDOMIZED CONTROLLED TRIAL. Journal of Southeast Asian Medical Research 6, pages e0127.
Crossref
Madeline R. Scott & Colleen A. McClung. 2021. Circadian Clock in Brain Health and Disease. Circadian Clock in Brain Health and Disease 153 168 .
William A. Wolfe. 2020. Nutrition in Kidney Disease. Nutrition in Kidney Disease 123 146 .
Shi‐Qi Zhao, Zhao‐Chun Shen, Bing‐Feng Gao & Ping Han. (2019) microRNA‐206 overexpression inhibits epithelial‐mesenchymal transition and glomerulosclerosis in rats with chronic kidney disease by inhibiting JAK/STAT signaling pathway. Journal of Cellular Biochemistry 120:9, pages 14604-14617.
Crossref
Joseph Chilcot & Joanna L. Hudson. (2018) Is successful treatment of depression in dialysis patients an achievable goal?. Seminars in Dialysis 32:3, pages 210-214.
Crossref
Yan Zhang, Binru Wang, Guangbin Sun, Guoliang Zhang, Ling Lu & Gengtian Liang. (2018) Carbon Dioxide Laser Microsurgery versus Low-Temperature Plasma Radiofrequency Ablation for T1a Glottic Cancer: A Single-Blind Randomized Clinical Trial. BioMed Research International 2018, pages 1-9.
Crossref
Lijuan Hou, Xiaoxia Wei, Ya Zhuo, Lei Qin, Fang Yang, Lili Zhang & Xinwen Song. (2018) GC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old age. Aging 10:9, pages 2252-2265.
Crossref